Neutralizing antibodies hamper IFNβ bioactivity and treatment effect on MRI in patients with MS

Authors:

Abstract
We measured neutralizing antibodies (NABs) and the in vivo biologic response to interferon-β on neopterin and β2-microglobulin blood levels. All NAB-negative patients had an in vivo biologic response (full or partial), whereas all high-level positive patients had no response. High-level NAB patients had more MRI activity than NAB-negative patients (p = 0.031). Patients with a full response had less MRI activity than patients without biologic response (p = 0.032).

This publication has 10 references indexed in Scilit: